185 related articles for article (PubMed ID: 23323589)
1. Management of anterior chamber dislocation of dexamethasone implant.
Kishore SA; Schaal S
Ocul Immunol Inflamm; 2013; 21(1):90-1. PubMed ID: 23323589
[TBL] [Abstract][Full Text] [Related]
2. Management of anterior chamber dislocation of a dexamethasone intravitreal implant: a case report.
Pacella F; Agostinelli E; Carlesimo SC; Nebbioso M; Secondi R; Forastiere M; Pacella E
J Med Case Rep; 2016 Oct; 10(1):282. PubMed ID: 27733187
[TBL] [Abstract][Full Text] [Related]
3. The clinical outcomes of surgical management of anterior chamber migration of a dexamethasone implant (Ozurdex®).
Kang H; Lee MW; Byeon SH; Koh HJ; Lee SC; Kim M
Graefes Arch Clin Exp Ophthalmol; 2017 Sep; 255(9):1819-1825. PubMed ID: 28601910
[TBL] [Abstract][Full Text] [Related]
4. Dexamethasone implant anterior chamber migration: risk factors, complications, and management strategies.
Khurana RN; Appa SN; McCannel CA; Elman MJ; Wittenberg SE; Parks DJ; Ahmad S; Yeh S
Ophthalmology; 2014 Jan; 121(1):67-71. PubMed ID: 23890421
[TBL] [Abstract][Full Text] [Related]
5. Intravitreal implant migration into anterior chamber in a post-vitrectomy eye with central retinal vein occlusion and persistent macular edema.
Turaka K; Kwong HM; De Souza S
Ophthalmic Surg Lasers Imaging Retina; 2013; 44(2):196-7. PubMed ID: 23402344
[TBL] [Abstract][Full Text] [Related]
6. Repositioning of dexamethasone intravitreal implant (Ozurdex) migrated into the anterior chamber.
Vela JI; Crespí J; Andreu D
Int Ophthalmol; 2012 Dec; 32(6):583-4. PubMed ID: 22763812
[TBL] [Abstract][Full Text] [Related]
7. Corneal toxicity after Ozurdex(®) migration into anterior chamber.
Bernal L; Estévez B
Arch Soc Esp Oftalmol; 2016 Jun; 91(6):292-4. PubMed ID: 26922138
[TBL] [Abstract][Full Text] [Related]
8. [Anterior chamber migration of intravitreal dexamethasone implant (Ozurdex®) in pseudophakic eyes: report of three cases].
Malclès A; Janin-Manificat H; Yhuel Y; Russo A; Agard E; El Chehab H; Ract Madoux G; Masse H; Burillon C; Dot C
J Fr Ophtalmol; 2013 Apr; 36(4):362-7. PubMed ID: 23318000
[TBL] [Abstract][Full Text] [Related]
9. Surgical Management of Anterior Chamber Migration of a Dexamethasone Intravitreal Implant.
Stelton CR; Townsend J; Peterson LT; Khurana RN; Yeh S
Ophthalmic Surg Lasers Imaging Retina; 2015; 46(7):756-9. PubMed ID: 26247457
[TBL] [Abstract][Full Text] [Related]
10. Anterior Chamber Migration of Ozurdex Implants.
Kayıkcıoğlu Ö; Doğruya S; Sarıgül C; Mayalı H; Kurt E
Turk J Ophthalmol; 2020 Apr; 50(2):115-122. PubMed ID: 32367704
[TBL] [Abstract][Full Text] [Related]
11. OFFICE MANAGEMENT OF OZURDEX IMPLANT DISLOCATION INTO THE ANTERIOR CHAMBER.
Ahuja AS; Jaraki JA; Halperin LS
Retin Cases Brief Rep; 2023 Mar; 17(2):170-172. PubMed ID: 33731604
[TBL] [Abstract][Full Text] [Related]
12. Management of Anterior Chamber Migration of Dexamethasone Intravitreal Implant.
Ha JY; Jang JY; Ji YS
Korean J Ophthalmol; 2017 Dec; 31(6):574-575. PubMed ID: 29230981
[No Abstract] [Full Text] [Related]
13. Spontaneous extrusion of a dexamethasone intravitreal implant (Ozurdex).
Ong J; Davidoss NH; Bhosale A; Balaratnasingam C
BMJ Case Rep; 2020 Nov; 13(11):. PubMed ID: 33148568
[TBL] [Abstract][Full Text] [Related]
14. Bilateral effect of unilateral dexamethasone intravitreal implant in a case of noninfectious uveitic macular edema and vitritis.
Habot-Wilner Z; Sorkin N; Goldenberg D; Goldstein M
Retin Cases Brief Rep; 2015; 9(2):151-3. PubMed ID: 25462131
[TBL] [Abstract][Full Text] [Related]
15. Simple technique for management of anterior chamber-migrated Ozurdex
Lee SH; Kang H; Byeon SH; Kim SS; Koh HJ; Lee SC; Kim M
Acta Ophthalmol; 2018 Nov; 96(7):e893-e894. PubMed ID: 29030918
[No Abstract] [Full Text] [Related]
16. Anterior chamber migration of dexamethasone intravitreal implant (Ozurdex®) through basal iridectomy (Ando) in a pseudophakic patient.
Stepanov A; Codenotti M; Ramoni A; Prati M; Jiraskova N; Rozsival P; Bandello F
Eur J Ophthalmol; 2016 Apr; 26(3):e52-4. PubMed ID: 26615950
[TBL] [Abstract][Full Text] [Related]
17. [Dislocation in anterior chamber of dexamethasone intravitreal device].
Cousin M; Hoffart L; Baeteman C; Matonti F
Can J Ophthalmol; 2013 Aug; 48(4):e62-3. PubMed ID: 23931482
[No Abstract] [Full Text] [Related]
18. Spontaneous Dissociation of Fluocinolone Acetonide Sustained Release Implant (Retisert) with Dislocation into the Anterior Chamber.
Chang PY; Kresch Z; Samson CM; Gentile RC
Ocul Immunol Inflamm; 2015; 23(6):454-7. PubMed ID: 24724735
[TBL] [Abstract][Full Text] [Related]
19. Pupilloplasty to prevent dexamethasone intravitreal implant migration to anterior chamber.
Medeiros Pinto J; Marques-Neves C
BMJ Case Rep; 2017 Apr; 2017():. PubMed ID: 28433977
[No Abstract] [Full Text] [Related]
20. INTRAVITREAL DEXAMETHASONE IMPLANT MIGRATION INTO THE ANTERIOR CHAMBER: A Multicenter Study From the Pan-American Collaborative Retina Study Group.
Gonçalves MB; Alves BQ; Moura R; Magalhães O; Maia A; Belfort R; de Ávila MP; Zas M; Saravia M; Lousas M; Wu L; Arevalo JF; Pacheco KD; Johnson T; Farah ME; Rodriguez FJ; Maia M;
Retina; 2020 May; 40(5):825-832. PubMed ID: 30789460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
